BackgroundThe SARS‐Cov‐2 pandemic has caused dermatologists around the world to adapt their practice in the aim of protecting patients with special clinical conditions such as those having skin cancers or premalignant conditions and some diagnostic or therapeutic programs would be suspended due to being infected to SARS‐CoV‐2. We focused the existing data in this regard through searching on PubMed, Google Scholar, and Scopus and tried to summarize recommendations for treating this group of patients in COVID era to provide a practical guide for clinicians.Recent findingsThe number of diagnosed skin cancers dropped significantly since the beginning of the pandemic, specially in the peaks of various variants of the SARS‐CoV‐2 infection. The new guidelines allowed even a 3‐month delay in excision and recommended surgery for non‐melanoma growing skin cancers.ConclusionDermatologists should perform a careful, individualized risk–benefit assessment for their patients and consider some changes in routine protocols such as having a delayed diagnostic or therapeutic intervention.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.